Fresenius Medical Care — Fact Sheet (February 2013)

4 slides from Fresenius Medical Care's fact sheet, February 2013

Slide 1: plasmaFlux P1dry/P2dry
Acute Therapy Systems plasmaFlux® P1dry/P2dry Membrane Plasma Separation (MPS) / Therapeutic Plasma Exchange (TPE) with the multiFiltrate
Slide 2: P1dry/P2dry plasmafilter optimised for clinical use with the multiFiltrate
P1dry/P2dry plasmafilter optimised for clinical use with the multiFiltrate INLINE steam-sterilised dry plasmafilter with two-layer structure and modelled membrane topology • Dry delivery enables simplified set-up with • Passage of blood cells through the membrane a shortening of the rinsing procedur
Slide 3: Sieving coefficient of plasmaproteins
Sieving coefficient of plasmaproteins (in vitro data with P2dry plasmafilter and human blood) 100 80 sieving coefficient (%) 60 40 20 0 Albumin IgG IgM LDL molecular weight (kDa) 66 150 940 2500 multiFiltrate Kit 16 MPS 16 IS MPS MPS P1dry Components and descriptions Order No. F00000215 F00004671 F0
Slide 4: Fresenius Medical Care head office and contact details
F00004882 GB (0,5 JNB-E&B 02.13) © Copyright 2013 Fresenius Medical Care Deutschland GmbH Head office: Fresenius Medical Care Deutschland GmbH · 61346 Bad Homburg v. d. H. · Germany Phone: +49 (0) 6172-609-0 · Fax: +49 (0) 6172-609-2191 www.fmc-ag.com